Mar 01, 2017 21:36 pm UTC| Business
MENLO PARK, Calif., March 01, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...
Condor Hospitality Trust Reports 2016 Results
Mar 01, 2017 21:32 pm UTC| Business
BETHESDA, Md., March 01, 2017 -- Condor Hospitality Trust, Inc. (NASDAQ:CDOR) (the “Company”) today announced results for the fourth quarter and year-ended December 31, 2016. “In early 2015, Condor embarked on...
OncoMed Pharmaceuticals to Report Fourth Quarter and Year End Financial Results on March 8, 2017
Mar 01, 2017 21:30 pm UTC| Business
REDWOOD CITY, Calif., March 01, 2017 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
Kinsale Capital Group, Inc. Reports 2016 Fourth Quarter and Year-End Results
Mar 01, 2017 21:30 pm UTC| Business
RICHMOND, Va., March 01, 2017 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) reported net income of $6.9 million for the fourth quarter of 2016 compared to $4.6 million for the fourth quarter of 2015. Net income was $26.2...
Mar 01, 2017 21:30 pm UTC| Business
JUPITER, Fla., March 01, 2017 -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging its patented and proprietary C1 expression system...
Heritage-Crystal Clean, Inc. Announces 2016 Fourth Quarter and Full Year Financial Results
Mar 01, 2017 21:30 pm UTC| Business
Highlights: Revenues for the fourth quarter increased 6.4%, to $106.7 million, compared to the fourth quarter of 2015Full-year cash flow from operations increased 32% to a record $38.1 million, an increase of $9.2...
Huttig Building Products, Inc. Announces Fourth Quarter and Full Year 2016 Results
Mar 01, 2017 21:30 pm UTC| Business
Fourth Quarter and Full Year 2016 Highlights: Net sales of $164.4 million and $713.9 million, respectivelyGross margin of 21.7% and 21.2 %, respectivelyNet loss of $0.2 million and net income of $16.3 million,...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood